CLINICAL_TRIALS
trial_result
· 2017-03-10
Clinical Trial Update: Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy [Phase 2]
Summary
A Phase 2 pilot trial evaluating ipilimumab in stage IV melanoma patients receiving palliative radiation therapy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-10